LBLilian Antwi Boateng

Lilian Antwi Boateng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lilian Antwi Boateng has a total of 80 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Acute and Chronic Leukemia in Sub‐Saharan Africa: A Systematic Review

    by Allwell A. Ayirebi, Stephen Twumasi, Linda K. Olaga, Benedict Sackey, Daniel N. M. Antonio, Richard O. Ansah, Eugene A. Ansah, John A. Sah, Enoch O. Anto, Yvonne Anang‐Quartey, et al.

    Background: The four primary subgroups of leukemia include chronic myeloid leukemia (CML), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and chronic lymphocytic leukemia (CLL). Very little is known about the regional variation of leukemia and subtypes in sub‐Saharan Africa (SSA). Aims: This systematic review focused on the prevalent cases reported in sub‐Saharan Africa, throwing more emphasis on treatment outcomes, follow up time and survival rates. Methods: A systematic review of studies on acute and chronic leukemia in sub‐Saharan Africa (SSA) was conducted using articles retrieved from PubMed, Scopus, Google Scholar, Embase and African‐specific databases such as African Journals Online (AJOL), covering publications from 1975 to July 15, 2025. Results: A total of 94 studies were subjected to initial screening from study titles. Thirty‐two (32) articles that met the inclusion criteria were selected for inclusion in this systematic review. Out of 2537 leukemia cases reported in the 32 studies, 1644 (64.80%) were acute and 893 (35.20%) were chronic. AML accounted for 947 (37.33%), 450 (17.74%) were ALL, 720 (28.38%) were CML, 173 (6.82%) were CLL, 2 (0.08%) were acute undifferentiated leukemia, 1 (0.04%) was mixed phenotype acute leukemia and 244 (9.62%) unclassified leukemias. Survival rates ranged from 2 weeks to 5 years. Fifty‐nine patients were lost to follow up and follow up time ranged from 11 months to 7 years. 273 (10.76%) leukemia related deaths were reported. Conclusion: This review found that acute leukemias were more prevalent than chronic leukemias, with AML emerging as the most frequently reported subtype. Survival durations ranged from a few weeks to five years; however, overall outcomes remained poor, characterized by high mortality rates and substantial loss to follow‐up. These findings underscore the urgent need for improved diagnostic capacity, standardized treatment protocols, and strengthened patient monitoring and follow‐up systems to enhance leukemia care and outcomes.

  • Open Access

    Diagnostic utility of fibrinolytic markers as indicators of pediatric Plasmodium falciparum malaria: a case-control study in the Offinso-North District, Ghana

    by Desmond Gyedu, Stephen Twumasi, Otchere Addai-Mensah, Lilian Antwi Boateng, Benedict Sackey, Abdul Wasid Abubakari, Samuel Kwarteng, Allwell Adofo Ayirebi, Belinda Nyuyelle Dery, Bastu Odoka, et al.

    Background: Severe Plasmodium falciparum ( P. falciparum ) malaria is associated with life-threatening complications, potentially linked to disturbed fibrinolysis. This study evaluated the plasma levels of key fibrinolytic markers; plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (t-PA), and D-dimer to assess their diagnostic and prognostic values in children with malaria in Ghana. Methods: We conducted a case-control study in the Offinso-North District, Ghana, recruiting 120 children aged 1–13 years. Participants were divided into three groups: a control group (n=40), an uncomplicated malaria group (n=55), and a severe malaria group (n=25), as defined by WHO guidelines. Plasma levels of t-PA, PAI-1, and D-dimer were measured using the sandwich Enzyme-Linked Immunosorbent Assay (ELISA) technique, and their diagnostic performance was assessed using the area under the receiver operating characteristic curve (AUROC). Results: Children with both uncomplicated and severe malaria had significantly higher plasma levels of PAI-1 and D-dimer, and significantly lower levels of t-PA, compared to the control group (p<0.05). D-dimer was identified as the strongest diagnostic marker for distinguishing all malaria cases from healthy controls (AUROC = 1.000, p<0.0001), demonstrating 98.8% (95% CI: 92.5–100) sensitivity and 100% (95% CI: 89.3–100) specificity. PAI-1 also demonstrated good diagnostic potential for both uncomplicated (AUROC = 0.752, p<0.0001) and severe malaria (AUROC = 0.811, p<0.0001) versus controls. For disease stratification, D-dimer significantly differentiated severe malaria from uncomplicated malaria (AUROC = 0.667, p=0.017). Conclusion: Malaria infection disrupts the balance between coagulation and fibrinolysis. Our findings establish D-dimer as an indicator of disease activity and a potentially valuable tool for risk stratification in pediatric malaria. We propose that integrating quantitative D-dimer and PAI-1 testing with standard microscopy could improve patient triage and risk stratification in resource-limited settings, enabling earlier identification of high-risk patients.

  • Acute transfusion reactions in sub‐Saharan Africa: A systematic review and meta‐analysis

    by Stephen Twumasi, Lilian Antwi Boateng, Alain Mayindu Ngoma, Henk Schonewille

    Background and Objectives: Sub‐Saharan Africa (SSA) faces significant challenges in implementing effective haemovigilance systems, thereby increasing the risk of adverse events following transfusion. This systematic review and meta‐analysis assessed the frequency, clinical patterns and determinants of acute transfusion reactions (ATRs) in the region, in order to inform evidence‐based prevention strategies. Materials and Methods: The review followed Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines, and the studies were a priori stratified by design. Pooled proportions were calculated using a random‐effects meta‐analysis. Results: Twenty‐six studies conducted in 13 countries and published up to 30 November 2024 were included; 15 were retrospective and 11 were prospective. When calculated per patient, the pooled ATR rate was 64 per 1000 patients in retrospective studies and 112 per 1000 patients in prospective studies. When estimated per unit transfused, the corresponding rates were 23 per 1000 units and 136 per 1000 units, respectively. The most frequently reported manifestations were consistent with febrile non‐haemolytic reactions (41.8%) and allergic reactions (24.9%). Potentially life‐threatening reactions occurred in 14%, and 0.94% resulted in death. Whole blood transfusion, multiple transfused units and previous transfusion exposure were identified as factors associated with ATR occurrence. Conclusion: ATRs are common in SSA and are strongly associated with the use of whole blood. The broader implementation of blood component therapy could substantially reduce their burden. Central to ATR prevention in the region are strengthening pre‐transfusion evaluation and testing, expanding leukoreduction, establishing robust in‐hospital haemovigilance systems and promoting appropriate blood use.

  • Open Access

    Neutrophil Gelatinase‐Associated Lipocalin and Neutrophil‐to‐Lymphocyte Ratio as Indicators of Nephropathy in Type 2 Diabetic Mellitus Patients in Ghana: A Case‐Control Study

    by Allwell Adofo Ayirebi, Wina Ivy Ofori Boadu, Stephen Twumasi, Samuel Kwarteng, Benedict Sackey, Lilian Antwi Boateng, Joseph Boachie, Samuel Essien‐Baidoo, Daniel Nii Martey Antonio, John Agyemang Sah, et al.

    Introduction: Serum neutrophil gelatinase‐associated lipocalin (sNGAL), a renal tubular marker, and neutrophil‐to‐lymphocyte ratio (NLR), a hematological inflammatory marker are two biomarkers that have recently received attention, because of their association with kidney disease. This study examined the diagnostic value sNGAL and NLR in type 2 diabetes mellitus (T2DM) patients with nephropathy. Materials and Methods: In this hospital‐based case‐control research, 97 T2DM participants and 70 healthy subjects were included. Participants' information was documented using a structured questionnaire and patient case records. Venous blood was drawn from each participant and early morning midstream urine samples were collected for blood and urine measurements respectively. Results: The prevalence of nephropathy among type 2 diabetics was 20.6%. sNGAL had a good performance (AUC = 0.793, p < 0.001) and NLR had a poor performance (AUC = 0.632, p = 0.082) for predicting diabetic nephropathy. An sNGAL cut‐off of 8.87 µg/L had 80.0% sensitivity and NLR threshold of 2.34 had 60.0% sensitivity and 72.8% specificity. In the multivariate binary logistic model, sNGAL showed a modest independent association, (aOR 1.25, 95% CI: 0.71–2.21, p = 0.014). In contrast, NLR was not significantly associated with nephropathy in the adjusted model (NLR: aOR 1.16, 95% CI: 0.60–2.24, p = 0.663). Conclusions: Whiles sNGAL showed superiority and is recommended, NLR showed no significant group difference and poor, non‐significant discrimination, indicating it is not a reliable standalone marker of diabetic nephropathy in this study.

  • Open Access

    Erythrocyte alloimmunization in children with sickle cell anemia living in Kilifi, Kenya

    by Michael Muteti, Ephy Akoko, Caudencia Nyakundi, George Mochamah, Johnstone Makale, Patrick Ombati, Brian Tawa, Steven Nyanjom, Lilian Antwi Boateng, Russell E. Ware, et al.


  • Open Access

    Engaging with young professionals in transfusion medicine: Insights from a needs assessment survey targeting an international cohort

    by Eunike C. McGowan, Antoine Lewin, Jian Ou‐Yang, Saikat Mandal, Nour Almozain, Abiy Belay Ambaye, Jannison Karlly Cavalcante Ribeiro, Lilian Antwi Boateng, Carla Luana Dinardo, Praiseldy Langi Sasongko, et al.

    Background and Objectives: Professionals who work or study in transfusion medicine under 40 years of age are considered young professionals (YPs) by the International Society of Blood Transfusion (ISBT). While the ISBT provides opportunities for YPs, their needs have to be assessed to customize initiatives in a way that could potentially improve their engagement. This survey aimed to assess the needs of YPs in transfusion medicine and understand their perspectives on future ISBT initiatives.Materials and Methods: Between January and February 2023, a 28‐question online survey was accessible through a generalized link across the ISBT network. Skip‐logic responses from 352 YPs, including 151 ISBT members and 201 non‐members, were analysed. Each question varied in the number of responders and, consequently, the number of responses.Results: Firstly, the most important needs of YPs from the survey were educational opportunities and training programmes, with 70% of respondents indicating for educational content in specific fields of transfusion. Secondly, Transfusion Today published by the ISBT (46.9%) ranked the highest in engagement, while ISBT Academy and Academy funding ranked the lowest (12.8%). ISBT members reported attending ISBT activities or using ISBT resources more often than non‐members, although this was not statistically significant. The primary barrier preventing both non‐members and ISBT members from engaging in ISBT activities was a lack of awareness.Conclusion: Raising awareness on a regular basis, a customized communication style (e.g., by a representative or different languages) and activities for non‐members may be key to improving YP engagement and expanding the ISBT network.

  • Open Access

    Haemato-urological profile and asymptomatic urinary tract infection in Ghanaian steady-state sickle cell disease patients.

    by Stephen Twumasi, Richard Owusu Ansah, Samuel Essien-Baidoo, Laud Anthony W. Basing, Alexander Yaw Debrah, Enoch Odame Anto, Allwell Adofo Ayirebi, Rebecca Asiamah-Broni, Waldemer Attivor, Eric Twum Ameyaw, et al.

    Background: Due to the reduction in immunity caused by auto-splenectomy and the consequent opsonic antibody shortage, patients with SCD are more susceptible to encapsulated organism infections, especially asymptomatic urinary tract infection (ASM-UTI). This study investigated the prevalence of asymptomatic urinary tract infection and compared urine and haematology parameters among SCD patients in Ghana to their healthy counterparts. Methods: In this study, 104 SCD participants and 80 non-SCD subjects were recruited. Participants' information was thoroughly documented using a well-structured questionnaire and patient case records. To evaluate the prevalence of asymptomatic urinary tract infection, a clean catch early morning urine was collected from each participant and cultured on Cystine-Lactose-Electrolyte Deficient (CLED). Also, venous blood was collected for the haematological profile of the study participants. Findings: Prevalence of ASM-UTI among SCD participants and non-SCD individuals were 22(21.2%) and 18(22.5%) respectively. S. aureus 15 (8.2%) accounted for the majority of the organisms isolated with the larger proportion 9(60.0%) being isolated from the SCD patients. This study found a statistical difference between SCD with ASM-UTI, without ASM-UTI, and non-SCD with respect to urine appearance (p=0.047), proteinuria (p=0.024), leucocyte (p<0.0001). Significantly high total WBC (p<0.0001), low platelets (p<0.0001), and low haemoglobin (p<0.0001) in SCD with ASM-UTI compared to non-SCD with ASM-UTI were also observed. Major risk factors associated with ASM-UTI includes a cloudy urine appearance (8.11, p<0.042), a positive (+1) and positive (+2) urine leucocytes and positive (+1) urine bilirubin with a significantly increased odd (7.65, p=0.001), (9.50, p=0.001) and (3.39, p=0.019) respectively of having ASM-UTI in SCD compared to having a clear urine appearance, a negative urine leucocyte, and a negative urine bilirubin. Conclusion: This study has shown ASM-UTI to be common in adult SCD participants with higher rate in females. This study also showed that ASM-UTI can exist alongside other clinical states such as anaemia, microalbuminuria, haematuria and proteinuria which are characteristics of kidney disease which can trigger crises in SCD participants.